Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China

Incremental value of amyloid PET in a tertiary memory clinic setting in China

“…29 An alternative explanation maybe the difference in prescription patterns in China, where the prevalence of cognition-specific drug medication prescription in memory clinics in China is much higher than in other countries. 34 This study shows previous findings, as we also compared the additional value in early-and late-onset patients. The early-onset cases showed a significantly higher rate of diagnostic changes compared with the late-onset cases.…”

“…Prior studies have shown that even after negative scans, dementia patients tend to continuing using cholinesterase inhibitor or memantine for treatment 29 . An alternative explanation maybe the difference in prescription patterns in China, where the prevalence of cognition‐specific drug medication prescription in memory clinics in China is much higher than in other countries 34 …”

“… 29 An alternative explanation maybe the difference in prescription patterns in China, where the prevalence of cognition‐specific drug medication prescription in memory clinics in China is much higher than in other countries. 34 …”

To the Editor and Readership of Alzheimer Disease and Associated Disorders

“…An additional important contribution by Kawada 1 was the recognition that antidementia agents may contribute to a lower number of necessary antipsychotic medications. Therein, Zhang et al 19 observed a higher odds of psychotic symptoms, agitation, and depressive symptoms were higher among those taking concurrent antidementia and antipsychotic medications. In addition, Suzuki et al 20 reported that antidementia medications were associated with a lower risk of concurrent psychotropic medications, including antipsychotic medications.…”

A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings

“…Second, Zhang et al 3 reported that the odds ratios (95% CIs) of psychotic symptoms, agitation, and depressive symptoms for the concomitant prescription of antidementia and antipsychotic medications were 1.84 (1.02 to 3.35), 1.91 (1.08 to 3.40), and 2.10 (1.12 to 3.94), respectively. I think that the risk of mortality by the initiation of antipsychotic medications should be evaluated by considering psychiatric disorders in relation to dementia.…”